Charles River Laboratories International, Inc. Share Price & Technical Analysis

CRL · $160.3 (+0.91%)

Healthcare / Diagnostics & Research

AI Score 23 · Bearish

$160.3

+0.91%

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in s

Price chart

Seasonality

May has 2 positive and 3 negative years (last 5 years shown)

-4% return in May, 2% avg return in past 3 year May month.

-19% return in 2026, 6% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
265%-15%-2%-4%-4%-19%
25-12%2%-9%-21%14%13%12%-2%-3%15%0%13%21%
24-8%18%7%-16%-9%-1%18%-19%1%-8%10%-8%-16%
2310%-10%-8%-5%2%8%0%-1%-6%-14%17%20%14%
22-12%-12%-2%-16%-2%-9%17%-17%-3%7%5%-6%-50%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 23/100

Bearish · Downtrend · Neutral

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Assessment segment offers in vitro and in vivo discovery services for the discovery, development, and safety testing of novel drugs, molecule compounds, oligonucleotides, and biotherapeutics, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services; and vivarium space services. The Manufacturing Solutions segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products; offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and contract development and manufacturing products and services. The company has strategic collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization. Additionally, it has a strategic alliance with Francis Crick Institute (Crick), Inc. for the development of Antibody-Drug Conjugate (ADC) drug discovery and development. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$8.16B

P/E ratio

52W high

$228.9

52W low

$132.6

Volume

4,27,461

Beta

1.45

Related stocks in Healthcare

Frequently asked questions

What is Charles River Laboratories International, Inc. share price today?
Charles River Laboratories International, Inc. (CRL) last traded around $160.3 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does CRL have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CRL. Download the app for real-time alerts.
How can I analyze Charles River Laboratories International, Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro